T1	Participants 91 174	laparoscopic radical hysterectomy and pelvic lymphadenectomy for gynecologic cancer
T2	Participants 288 376	laparoscopic radical hysterectomy and pelvic lymphadenectomy to treat gynecologic tumors
T3	Participants 506 593	Gynecologic Oncology Unit of the Catholic University of the Sacred Heart in Rome, Italy
T4	Participants 604 1005	Fifty patients with early cervical cancer (FIGO stages IA2, IB1, IIA <2 cm) or locally advanced cervical cancer (FIGO stages IB2, IIA >2cm, IIB) who received neoadjuvant treatment (chemotherapy or radiochemotherapy) and demonstrated a complete or partial clinical response and early stage endometrioid endometrial cancer (FIGO stages IB, II) were randomly assigned to undergo TB (arm A) or SES (arm B)
T5	Participants 1020 1091	Laparoscopic radical hysterectomy with bilateral pelvic lymphadenectomy
T6	Participants 1177 1288	Fifty patients were available for analysis, with 25 women randomly assigned to TB (arm A) and 25 to SES (arm B)
T7	Participants 1982 2011	patients with uterine cancer.
